Skip to main content
Erschienen in: Journal of Translational Medicine 1/2022

Open Access 01.12.2022 | Correction

Correction: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients

verfasst von: Zengwei Tang, Yuan Yang, Wen Chen, Enliang Li, Tingbo Liang

Erschienen in: Journal of Translational Medicine | Ausgabe 1/2022

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The original article can be found online at https://​doi.​org/​10.​1186/​s12967-022-03249-2.
The original version of this article was revised: Figure 2 was published incorrectly as well as captions of Figure 2 and Figure 7 need to be extended. Funding note was incorrect and need to be corrected.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Correction: Journal of Translational Medicine (2022) 20:49 https://​doi.​org/​10.​1186/​s12967-022-03249-2

Following publication of the original article [1], we have been notified that the Figure 2 was published incorrectly. Also, the Figures 2 and 7 captions should be extended and Funding note needs to be corrected.
They should be as follows:
Fig. 7 Demethylation at enhancer region (cg08889930) significantly negatively correlated with NUP37 mRNA expression. A Diagram showing the CpG islands in the promoter region of human NUP37 gene. B Heatmap showing overall methylation patterns in the DNA sequence of human NUP37 gene. C Correlation heatmap visualizing the relationship between NUP37 mRNA expression and the methylation level of CpG island at DNA sequence of NUP37 gene. D–F Scatter plot showing that NUP37 mRNA expression significantly negatively correlated with the methylation level of cg08889930 in HCC patients from 3 independent datasets. G NUP37 mRNA expression in Huh7 cells significantly increased after decitabine treatment ***p < 0.001, based on ANOVA. H NUP37 mRNA expression in Huh7 cells significantly reduced after treatment with CPI-455. ****p < 0.0001, based on ANOVA. I–J Representative immunoblot of HCC cells (Huh7) lysates showing that decitabine increased NUP37 protein expression and CPI-455 decreased NUP37 protein expression. The NUP37, GAPDH and MCM2 (Fig 6I-J) bands of Huh7 cell lysates were obtained from same gel.
Funding note: This study was funded by the grants from National Key Research and Development Program (No 2019YFC1316000) and the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents. The funders played no roles in the study design, the collection, analysis and interpretation of data, the writing of the report, and the decision to submit the article for publication.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Correction: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients
verfasst von
Zengwei Tang
Yuan Yang
Wen Chen
Enliang Li
Tingbo Liang
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
Journal of Translational Medicine / Ausgabe 1/2022
Elektronische ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-022-03766-0

Weitere Artikel der Ausgabe 1/2022

Journal of Translational Medicine 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.